The condemnations keep coming after five diabetes experts were escorted out of an ADA meeting for handing out copies of an ...
Federal health regulators on Tuesday signed off on the first new sunscreen ingredient for the U.S. market in more than 25 ...
A new analysis found the average drug shortage in 2025 had lasted 5.3 years, exceeding the 4.3 years seen in 2024 ...
A government-commissioned study had been meant to inform new dietary guidelines, and found risks associated with even light ...
GSK agreed to buy Nuvalent, a cancer drug developer, in a deal worth $10.6 billion, as the company continues its expansion in ...
John writes about the politics of health care, and he is the author of the twice-weekly D.C. Diagnosis newsletter. You can reach John on Signal at John_Wilkerson.07. Tara covers the business of health ...
NATIONAL HARBOR, Md. — Hospital finance leaders rolled out the red carpet for the Trump administration’s new health care ...
OHRP has experienced an unprecedented exodus of ethics expertise, raising concerns about its ability to effectively protect ...
A senior NIH scientist and his research fellow were charged with smuggling vials of deactivated mpox virus into the country ...
The FDA has missed a self-imposed deadline to ban the use of electrical shock devices in people with intellectual ...
An NIH advisor told researchers gathered at the American Diabetes Association conference that MAHA goals match the agency's ...
A compound named “substance God help me” by its longtime champion could benefit from RFK Jr.'s favorable views on using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results